Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of SYHA1402 tablets in Chinese patients with diabetic peripheral neuropathy
CTR20212247Phase 2Active
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of syha1402 in diabetic polyneuropathy (DPN), sponsored by CSPC ZhongQi Pharmaceutical Technology. Started Dec 2021; status: active.
02
Drugs
syha1402
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on CTR20212247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212247.